Madagascar vs Niger: The number of people with susceptibility test result for rifampicin
Madagascar
15.83
in 2021
Niger
11.2
in 2021
Madagascar rank
137th
Niger rank
138th
The number of people with susceptibility test result for rifampicin over time
- Madagascar
- Niger
How they compare
Madagascar currently reports 15.83 against 11.2 in Niger, a difference of 4.63.
That makes Madagascar's figure about 1.4 times Niger's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Niger ahead.
Madagascar ranks 137th and Niger ranks 138th of 146 countries.
Niger has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Madagascar | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0111 | 1.85 | 1.84 | Niger |
| 2020s | 7.93 | 10.1 | 2.18 | Niger |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Madagascar or Niger?
- Madagascar, at 15.83 against 11.2 in Niger as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Madagascar and Niger?
- 4.63, with Madagascar ahead.
- How many years of comparable data are there for Madagascar and Niger?
- 5 years are reported by both, from 2017 to 2021.
- How do Madagascar and Niger rank globally for the number of people with susceptibility test result for rifampicin?
- Madagascar ranks 137th and Niger ranks 138th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.